Cargando…

Newborns with Bloody Stools—At the Crossroad between Efficient Management of Necrotizing Enterocolitis and Antibiotic Stewardship

The onset of bloody stools in neonates often results in antibiotic treatment for suspected necrotizing enterocolitis (NEC). Food protein-induced allergic proctocolitis (FPIAP) is an often-neglected differential diagnosis. We performed a retrospective analysis of antibiotic exposure at our tertiary c...

Descripción completa

Detalles Bibliográficos
Autores principales: Heyne-Pietschmann, Marie, Lehnick, Dirk, Spalinger, Johannes, Righini-Grunder, Franziska, Buettcher, Michael, Lehner, Markus, Stocker, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698526/
https://www.ncbi.nlm.nih.gov/pubmed/34943679
http://dx.doi.org/10.3390/antibiotics10121467
_version_ 1784620299168251904
author Heyne-Pietschmann, Marie
Lehnick, Dirk
Spalinger, Johannes
Righini-Grunder, Franziska
Buettcher, Michael
Lehner, Markus
Stocker, Martin
author_facet Heyne-Pietschmann, Marie
Lehnick, Dirk
Spalinger, Johannes
Righini-Grunder, Franziska
Buettcher, Michael
Lehner, Markus
Stocker, Martin
author_sort Heyne-Pietschmann, Marie
collection PubMed
description The onset of bloody stools in neonates often results in antibiotic treatment for suspected necrotizing enterocolitis (NEC). Food protein-induced allergic proctocolitis (FPIAP) is an often-neglected differential diagnosis. We performed a retrospective analysis of antibiotic exposure at our tertiary center from 2011 to 2020 that included three time periods of differing antimicrobial stewardship goals. We compared these data with the conventional treatment guidelines (modified Bell’s criteria). In our cohort of 102 neonates with bloody stools, the length of antibiotic exposure was significantly reduced from a median of 4 to 2 days. The proportion of treated neonates decreased from 100% to 55% without an increase in negative outcomes. There were 434 antibiotic days. Following a management strategy according to modified Bell’s criteria would have led to at least 780 antibiotic days. The delayed initiation of antibiotic treatment was observed in 7 of 102 cases (6.9%). No proven NEC case was missed. Mortality was 3.9%. In conclusion, with FPIAP as a differential diagnosis of NEC, an observational management strategy in neonates with bloody stools that present in a good clinical condition seems to be justified. This may lead to a significant reduction of antibiotic exposure. Further prospective, randomized trials are needed to prove the safety of this observational approach.
format Online
Article
Text
id pubmed-8698526
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86985262021-12-24 Newborns with Bloody Stools—At the Crossroad between Efficient Management of Necrotizing Enterocolitis and Antibiotic Stewardship Heyne-Pietschmann, Marie Lehnick, Dirk Spalinger, Johannes Righini-Grunder, Franziska Buettcher, Michael Lehner, Markus Stocker, Martin Antibiotics (Basel) Article The onset of bloody stools in neonates often results in antibiotic treatment for suspected necrotizing enterocolitis (NEC). Food protein-induced allergic proctocolitis (FPIAP) is an often-neglected differential diagnosis. We performed a retrospective analysis of antibiotic exposure at our tertiary center from 2011 to 2020 that included three time periods of differing antimicrobial stewardship goals. We compared these data with the conventional treatment guidelines (modified Bell’s criteria). In our cohort of 102 neonates with bloody stools, the length of antibiotic exposure was significantly reduced from a median of 4 to 2 days. The proportion of treated neonates decreased from 100% to 55% without an increase in negative outcomes. There were 434 antibiotic days. Following a management strategy according to modified Bell’s criteria would have led to at least 780 antibiotic days. The delayed initiation of antibiotic treatment was observed in 7 of 102 cases (6.9%). No proven NEC case was missed. Mortality was 3.9%. In conclusion, with FPIAP as a differential diagnosis of NEC, an observational management strategy in neonates with bloody stools that present in a good clinical condition seems to be justified. This may lead to a significant reduction of antibiotic exposure. Further prospective, randomized trials are needed to prove the safety of this observational approach. MDPI 2021-11-29 /pmc/articles/PMC8698526/ /pubmed/34943679 http://dx.doi.org/10.3390/antibiotics10121467 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Heyne-Pietschmann, Marie
Lehnick, Dirk
Spalinger, Johannes
Righini-Grunder, Franziska
Buettcher, Michael
Lehner, Markus
Stocker, Martin
Newborns with Bloody Stools—At the Crossroad between Efficient Management of Necrotizing Enterocolitis and Antibiotic Stewardship
title Newborns with Bloody Stools—At the Crossroad between Efficient Management of Necrotizing Enterocolitis and Antibiotic Stewardship
title_full Newborns with Bloody Stools—At the Crossroad between Efficient Management of Necrotizing Enterocolitis and Antibiotic Stewardship
title_fullStr Newborns with Bloody Stools—At the Crossroad between Efficient Management of Necrotizing Enterocolitis and Antibiotic Stewardship
title_full_unstemmed Newborns with Bloody Stools—At the Crossroad between Efficient Management of Necrotizing Enterocolitis and Antibiotic Stewardship
title_short Newborns with Bloody Stools—At the Crossroad between Efficient Management of Necrotizing Enterocolitis and Antibiotic Stewardship
title_sort newborns with bloody stools—at the crossroad between efficient management of necrotizing enterocolitis and antibiotic stewardship
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698526/
https://www.ncbi.nlm.nih.gov/pubmed/34943679
http://dx.doi.org/10.3390/antibiotics10121467
work_keys_str_mv AT heynepietschmannmarie newbornswithbloodystoolsatthecrossroadbetweenefficientmanagementofnecrotizingenterocolitisandantibioticstewardship
AT lehnickdirk newbornswithbloodystoolsatthecrossroadbetweenefficientmanagementofnecrotizingenterocolitisandantibioticstewardship
AT spalingerjohannes newbornswithbloodystoolsatthecrossroadbetweenefficientmanagementofnecrotizingenterocolitisandantibioticstewardship
AT righinigrunderfranziska newbornswithbloodystoolsatthecrossroadbetweenefficientmanagementofnecrotizingenterocolitisandantibioticstewardship
AT buettchermichael newbornswithbloodystoolsatthecrossroadbetweenefficientmanagementofnecrotizingenterocolitisandantibioticstewardship
AT lehnermarkus newbornswithbloodystoolsatthecrossroadbetweenefficientmanagementofnecrotizingenterocolitisandantibioticstewardship
AT stockermartin newbornswithbloodystoolsatthecrossroadbetweenefficientmanagementofnecrotizingenterocolitisandantibioticstewardship